236 related articles for article (PubMed ID: 6606427)
41. Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5 alpha-dihydrotestosterone and the synthetic androgen methyltrienolone.
Kaufman M; Pinsky L; Bowin A; Au MW
Am J Med Genet; 1984 Jul; 18(3):493-507. PubMed ID: 6332533
[TBL] [Abstract][Full Text] [Related]
42. Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
Schulz P; Bauer HW; Fittler F
Biol Chem Hoppe Seyler; 1985 Nov; 366(11):1033-9. PubMed ID: 3878148
[TBL] [Abstract][Full Text] [Related]
43. Evidence for an androgen receptor in the seminiferous tubules of the human testis.
Winters SJ; Troen P
J Steroid Biochem; 1984 Sep; 21(3):315-20. PubMed ID: 6333554
[TBL] [Abstract][Full Text] [Related]
44. Hormonal regulation in two rat mammary cancer cell lines: glucocorticoid and androgen receptors.
Vignon F; Chan PC; Rochefort H
Mol Cell Endocrinol; 1979 Feb; 13(2):191-202. PubMed ID: 109329
[TBL] [Abstract][Full Text] [Related]
45. Multiple binding components for methyltrienolone in canine prostatic epithelial cells.
Turcotte G; Chapdelaine A; Chevalier S
J Steroid Biochem; 1988 Dec; 31(6):955-62. PubMed ID: 3264358
[TBL] [Abstract][Full Text] [Related]
46. Binding of methyltrienolone to various androgen-dependent and androgen-responsive tissues in four animal species.
Dubé JY; Tremblay RR; Chapdelaine P
Horm Res; 1976; 7(6):333-40. PubMed ID: 1028725
[TBL] [Abstract][Full Text] [Related]
47. Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion.
Shapiro E; Lippman ME
J Steroid Biochem; 1985 Jan; 22(1):15-20. PubMed ID: 3871880
[TBL] [Abstract][Full Text] [Related]
48. Steroid binding proteins in rat and human prostate.
Traish AM; Muller RE; Burns ME; Wotiz HH
Prog Clin Biol Res; 1981; 75A():417-34. PubMed ID: 6978489
[No Abstract] [Full Text] [Related]
49. Androgens control androgen-binding sites in rat epididymis.
Tezón JG; Blaquier JA
Endocrinology; 1983 Sep; 113(3):1025-30. PubMed ID: 6347665
[TBL] [Abstract][Full Text] [Related]
50. Differences in the physicochemical characteristics of androgen-receptor complexes formed in vivo and in vitro.
Traish AM; Müller RE; Wotiz HH
Endocrinology; 1984 May; 114(5):1761-9. PubMed ID: 6609069
[TBL] [Abstract][Full Text] [Related]
51. Characterization and quantification of the androgen and glucocorticoid receptors in cytosol from rat skeletal muscle.
Snochowski M; Dahlberg E; Gustafsson JA
Eur J Biochem; 1980 Oct; 111(2):603-16. PubMed ID: 6970125
[TBL] [Abstract][Full Text] [Related]
52. Modulation of the cytosolic androgen receptor in striated muscle by sex steroids.
Rance NE; Max SR
Endocrinology; 1984 Sep; 115(3):862-6. PubMed ID: 6611254
[TBL] [Abstract][Full Text] [Related]
53. Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole cell assay system.
De Pergola G; Xu XF; Yang SM; Giorgino R; Bjorntorp P
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):553-8. PubMed ID: 2278839
[TBL] [Abstract][Full Text] [Related]
54. The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors.
Schilling K; Liao S
Prostate; 1984; 5(6):581-8. PubMed ID: 6333679
[TBL] [Abstract][Full Text] [Related]
55. Photoaffinity labelling of androgen receptors with 17 beta-hydroxy-17 alpha-[3H]methyl-4,9,11-estratrien-3-one.
Brinkmann AO; Kuiper GG; de Boer W; Mulder E; van der Molen HJ
Biochem Biophys Res Commun; 1985 Jan; 126(1):163-9. PubMed ID: 3871607
[TBL] [Abstract][Full Text] [Related]
56. Conversion of transformed androgen and glucocorticoid receptors to higher molecular forms.
Ohara-Nemoto Y; Nemoto T; Yoshida M; Ota M
Biochem Int; 1986 Mar; 12(3):397-402. PubMed ID: 3486659
[TBL] [Abstract][Full Text] [Related]
57. A quantitative assay for the cytoplasmic androgen receptor using [3H]dihydrotestosterone in the presence of NAD+-nucleosidase.
Moeller H; Oettling G; Fiederer B; Brügmann G
Acta Endocrinol (Copenh); 1983 Jan; 102(1):153-60. PubMed ID: 6297214
[TBL] [Abstract][Full Text] [Related]
58. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
[TBL] [Abstract][Full Text] [Related]
59. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
60. [Demonstration of a nuclear androgen receptor in erythroblasts obtained by culture of human bone marrow].
Claustres M; Sultan C
C R Seances Soc Biol Fil; 1985; 179(5):645-55. PubMed ID: 2938693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
